课题基金 / 基金详情

MECHANISM OF REGULATION OF TELOMERASE EXPRESSION, AND EXPERIMENTAL STUDY ON CANCER GENE THERAPY USING ITS PROMOTER.

MECHANISM OF REGULATION OF TELOMERASE EXPRESSION, AND EXPERIMENTAL STUDY ON CANCER GENE THERAPY USING ITS PROMOTER.
端粒酶表达调控机制及其启动子治疗癌症基因的实验研究。
批准号:
12470330
负责人:
NAMIKI Mikio
金额:
$6.78万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

NAMIKI Mikio的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Human telomerase reverse transcriptase (hTERT) is the catalytic subunit of telomerase, which is highly active in immortalized cells. We herein carried out basic experiments on cancer gene therapy utilizing the hTERT promoter. The core promoter region was identified by deletion analysis, and demethylation of this region accelerated the expression of p16 and E-cadherin. Cytosine deaminase gene was ligated in downstream of hTERT promoter. In vitro experiments demonstrated that cell- kill effect was only seen in cancer cells not in normal cells. Tandem repeat promoter is now under construction for creating more active and specific tool in gene therapy. Adenovirus vector containing hTERT promoter and CD was constructed, and used in vivo experiments. The data was promising and could be widely utilized in the field of cancer gene therapy because of its specificity.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
Koh E, Kanaya J, Namiki M: "Adrenal steroids in human prostate cancer cell lines"Arch Androl. 46. 117-125 (2001)
Koh E、Kanaya J、Namiki M:“人类前列腺癌细胞系中的肾上腺类固醇”Arch Androl。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kyo S, Kondo S: "Treatment of malignant glioma cells with the transfer of constitutively active caspase-6 using the human telomerase catalytic subunit (hTERT) gene"Cancer Res. 61. 5796-5802 (2001)
Kyo S、Kondo S:“使用人端粒酶催化亚基 (hTERT) 基因转移组成型活性 caspase-6 来治疗恶性神经胶质瘤细胞”Cancer Res。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kato H, Namiki M, et al.: "Potential benefits of combining cytosine deaminuse/fluorocytosine(CD/5-FC)gene therapy and irradiation for prostate cancer"Int J Urol. (in press). (2002)
Kato H、Namiki M 等人:“结合胞嘧啶脱氨/氟胞嘧啶 (CD/5-FC) 基因疗法和放射治疗前列腺癌的潜在益处”Int J Urol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Koh E, Namiki M, et al.: "Adrenol steroids in human prostate cancer cell lines"Arch Andrul. 46. 117-125 (2001)
Koh E、Namiki M 等人:“人类前列腺癌细胞系中的肾上腺素类固醇”Arch Andrul。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
13
    Elucidation of mechanisms of the prostate cancer progress in consideration of AR Axis / microenvironment and the construction of the innovative treatment strategy
    • 批准号:
      26293350
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.4万
    • 财政年份:
      2014
    • 负责人:
      NAMIKI Mikio
    • 依托单位:
    Exploration of gene impairments assosiated with non-coding DNA, which involves in an Alu sequences causing male infertility
    • 批准号:
      25670679
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2013
    • 负责人:
      NAMIKI Mikio
    • 依托单位:
    Solution of the molecular mechanism about proliferation / recurrence of the prostate cancer and the architecture of the comprehensive treatment strategy for he prostate cancer
    • 批准号:
      23390379
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.49万
    • 财政年份:
      2011
    • 负责人:
      NAMIKI Mikio
    • 依托单位:
    The basic research for elucidation of molecular mechanism of the prostate cancer recurrence and the treatment strategy construction
    • 批准号:
      20390421
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.48万
    • 财政年份:
      2008
    • 负责人:
      NAMIKI Mikio
    • 依托单位:
    海外基金